| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |